Meyka Pro banner
908 Devices Inc.

908 Devices Inc. (MASS) Stock Overview

Explore 908 Devices Inc.’s financial performance, market position, analyst ratings, and future outlook.

MASSNASDAQ
HealthcareMedical - Specialties
$10.98
$1.06(10.69%)
U.S. Market opens in 7h 15m

908 Devices Inc. (MASS)

Meyka AI Score

Z

Key Financials

Market Cap450.5M
P/E Ratio-10.58
EPS (TTM)$-0.60
ROE-0.25%
Fundamental Analysis

AI Price Forecasts

1 Month$13.33
3 Months$8.53
1 Year Target$8.21

MASS Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of 908 Devices Inc. (NASDAQ: MASS) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, 908 Devices Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of MASS on the NASDAQ shows an RSI of 65.14, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $8.21 for the NASDAQ listing.

Key metrics behind 908 Devices Inc.'s NASDAQ-traded stock include a P/E ratio of -10.58 and a market capitalization of 450.5M. Combined with our AI analysis, these give both institutional and retail investors a clear view of MASS on the NASDAQ.

Price Performance (NASDAQ: MASS)

1-Day Change
10.69%
5-Day Change
15.70%
1-Month Change
7.75%
3-Month Change
27.97%
6-Month Change
76.53%
Year-to-Date (YTD) Change
109.14%
1-Year Change
68.15%
3-Year Change
79.41%
5-Year Change
-69.38%
All-Time (Max) Change
-77.59%

Contact Information

857 254 1500
44 3rd Avenue, Burlington, MA, 01803

Company Facts

1,720 Employees
IPO DateDec 18, 2020
CountryUS
Actively Trading

Frequently Asked Questions